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The natural product dibenzoylmethane (1, 3-Diphenyl-propane-1, 3-dione, 
DBM), obtained from the licorice, is widely used in a variety of fields, such as solvent 
extraction, organic synthesis, chemical analysis, stereochemistry, thermoplastic plastic 
and heat-stable inhibitor. Recently, DBM has been found to exhibit numerous 
biological activities including anti-oxidation, anti-inflammatory, anti-HIV, anti-tumor, 
and anti-angiogenesis activities. Besides, it has the merits of hypo toxicity, high 
biological exploitability and abound resources and induce cell apoptosis. Thus, DBM 
is identified as a promising antineoplastic agent. In the present study, we used DBM 
as the nuclear parent and synthesized a series of β-diketone analogues. The structure 
of the products was identified by NMR, MS and IR. We investegated the anti-tumor 
activity of these compounds on BEL-7402, HT1080 and Hela cells by CCK8 assay, 
and researched the relationship between the structure of these compounds and their 
anti-tumor activities, which can be the basis of theory and the experiment on 
researching anti-tumor active rule. 
According to the functional group of β-diketone, we designed and synthesized a 
series of compounds containing the structure of β-diketone to study the 
structure-activity relationship and the mechanism of inducing tumor cell apoptosis. 
We found that β-diketone was a cytotoxic functional group and with the increase in 
the ratio of enol to keto, cytotoxicity of β-diketone enhances. In vitro, β-diketone 
formed non-classical Michael adducts with sulfydryl nucleophile NAC as nucleophilic 
addition. Hydroxyl group on α position of aromatic ring could strengthen anti-tumor 
activity of β-diketone. These data obviously indicated the role of β-diketone in 
toxicity and revealed that β-diketone configuration affected cytotoxicity by governing 
detoxification through the rate of adduct formation. Moreover, we found that 
DBM-induced apoptotic cell death was accompanied by upregulation of IRE1, CHOP, 















chemopreventive activity of DBM resulted from its ability to induce cell apoptosis by 
accumulation of endoplasmic reticulum stress through the mitochondrial pathway. 
 















缩 略 语 
符号                         英文含义                        中文含义 
OD                        optical density                        光密度 
IC50               half-maximal inhibitory concentration          半数抑制浓度 
DMSO                   Dimethyl Sulphoxide                   二甲亚砜 
PBS                   Phosphate-buffered saline               磷酸缓冲液 
SDS                    Sodium dodecyl sulfate            十二烷基磺酸钠 
PMSF              Phenylmethanesulfonyl fluoride            苯甲基磺酰氟 
NAC                     N-acetyl-L-cysteine           N-乙酰-L-半胱氨酸 
P-TsOH                 p-toluenesulfonic acid               对甲基苯磺酸 
CHOP                 C/EBP Homology Protein            C/EBP 同源蛋白 
CYC                       Cytochrome C                       细胞色素 C 
ESI-MS                 Electrospray Ionization Mass        电喷雾电离质谱 
NMR                 Nuclear Magnetic Resonance              核磁共振 
HPLC                 High Performance Liquid              高效液相色谱 
h                             Hour                            小时 
min                          Minute                           分钟 
r.t.                        Room Temperature                    室温 
Py                           Pyridine                          吡啶 
TLC                  Thin Layer Chromatography              薄层色谱 
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